ProQR Therapeutics N.V.(PRQR)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

PRQR ProQR Therapeutics N.V.

交易中 12-23 10:43:12 EST

2.59

-0.04

-1.71%

最高2.70	最低2.52	成交量5.68万
今开2.70	昨收2.63	日振幅6.84%
总市值2.67亿	流通市值2.05亿	总股本1.03亿
成交额14.55万	换手率0.07%	流通股本7,938万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"PRQR","market":"US","secType":"STK","nameCN":"ProQR Therapeutics N.V.","latestPrice":2.585,"timestamp":1734968591102,"preClose":2.63,"halted":0,"volume":56812,"delay":0,"floatShares":79377912,"shares":103203733,"eps":-0.334691,"marketStatus":"交易中","marketStatusCode":2,"change":-0.045,"latestTime":"12-23 10:43:12 EST","open":2.7,"high":2.7,"low":2.52,"amount":145501.8210884,"amplitude":0.068441,"askPrice":2.59,"askSize":790,"bidPrice":2.58,"bidSize":125,"shortable":3,"etf":0,"ttmEps":-0.334691,"exchange":"NASDAQ","tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1734987600000},"adr":0,"listingDate":1411012800000,"adjPreClose":2.63,"adrRate":0,"postHourTrading":{"tag":"盘后","latestPrice":2.63,"preClose":2.63,"latestTime":"16:00 EST","volume":1700,"amount":4471,"timestamp":1734728401342},"volumeRatio":0.263589,"impliedVol":0.7758,"impliedVolPercentile":0.1315},"requestUrl":"/m/hq/s/PRQR/wiki","defaultTab":"wiki","newsList":[{"id":"2492618207","title":"Proqr Therapeutics N.V.盘中异动 股价大跌5.44%","url":"https://stock-news.laohu8.com/highlight/detail?id=2492618207","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492618207?lang=zh_cn&edition=full","pubTime":"2024-12-18 23:05","pubTimestamp":1734534311,"startTime":"0","endTime":"0","summary":"北京时间2024年12月18日23时05分，Proqr Therapeutics N.V.股票出现异动，股价急速下跌5.44%。截至发稿，该股报2.78美元/股，成交量5.0789万股，换手率0.05%，振幅4.42%。Proqr Therapeutics N.V.股票所在的生物技术行业中，整体跌幅为0.42%。其相关个股中，Polyrizon Ltd.、Cognition Therapeutics, Inc.、Cardio Diagnostics Holdings Inc C/Wts  To Pur Com涨幅较大，Polyrizon Ltd.、Cognition Therapeutics, Inc.、Tc Biopharm  Plc较为活跃，换手率分别为1917.73%、396.30%、277.51%，振幅较大的相关个股有Polyrizon Ltd.、Cognition Therapeutics, Inc.、Nkgen Biotech Inc C/Wts 31/05/2028，振幅分别为227.62%、96.72%、66.83%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241218230511984cb34d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241218230511984cb34d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","PRQR"],"gpt_icon":0},{"id":"2491697312","title":"Proqr Therapeutics N.V.盘中异动 急速下挫5.53%","url":"https://stock-news.laohu8.com/highlight/detail?id=2491697312","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491697312?lang=zh_cn&edition=full","pubTime":"2024-12-16 22:38","pubTimestamp":1734359922,"startTime":"0","endTime":"0","summary":"北京时间2024年12月16日22时38分，Proqr Therapeutics N.V.股票出现波动，股价快速跳水5.53%。截至发稿，该股报2.67美元/股，成交量7.1814万股，换手率0.07%，振幅3.53%。Proqr Therapeutics N.V.股票所在的生物技术行业中，整体涨幅为0.46%。其相关个股中，Nrx Pharmaceuticals Inc C/Wts 24/05/2026 、Cardio Diagnostics Holdings Inc C/Wts  To Pur Com、Viridian Therapeutics, Inc.涨幅较大，Tonix Pharmaceuticals Holding Corp.、Dermata Therapeutics, Inc.、Genprex, Inc.较为活跃，换手率分别为35.50%、31.42%、27.96%，振幅较大的相关个股有Tonix Pharmaceuticals Holding Corp.、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025、Nkgen Biotech Inc C/Wts 31/05/2028，振幅分别为19.33%、19.23%、18.84%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241216223842a1f3464e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241216223842a1f3464e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","PRQR"],"gpt_icon":0},{"id":"2491374672","title":"Proqr Therapeutics N.V.盘中异动 早盘大幅下跌5.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2491374672","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491374672?lang=zh_cn&edition=full","pubTime":"2024-12-13 23:45","pubTimestamp":1734104758,"startTime":"0","endTime":"0","summary":"北京时间2024年12月13日23时45分，Proqr Therapeutics N.V.股票出现异动，股价大幅下跌5.17%。Proqr Therapeutics N.V.股票所在的生物技术行业中，整体跌幅为0.33%。Proqr Therapeutics N.V.公司简介：ProQR Therapeutics NV is a biopharmaceutical company, which engages in the discovery and development of Ribonucleic Acid RNA based therapeutics for the treatment of genetic disorders. Its initial focus is on the development of a disease-modifying therapy for the treatment of cystic fibrosis. The company was founded by Daniel de Boer, Gerard Platenburg, Henri Termeer and Dinko Valerio on February 21, 2012 and is headquartered in Leiden, the Netherlands.（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241213234559a1ec55f8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241213234559a1ec55f8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","PRQR"],"gpt_icon":0},{"id":"2490402545","title":"Proqr Therapeutics N.V.盘中异动 大幅跳水5.07%报3.28美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2490402545","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490402545?lang=zh_cn&edition=full","pubTime":"2024-12-11 04:52","pubTimestamp":1733863972,"startTime":"0","endTime":"0","summary":"北京时间2024年12月11日04时52分，Proqr Therapeutics N.V.股票出现波动，股价急速下挫5.07%。截至发稿，该股报3.28美元/股，成交量44.4218万股，换手率0.42%，振幅6.96%。Proqr Therapeutics N.V.股票所在的生物技术行业中，整体跌幅为0.83%。其相关个股中，Chimerix, Inc.、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Uniqure N.V.涨幅较大，Psyence Biomedical Ltd.、Processa Pharmaceuticals, Inc.、Chimerix, Inc.较为活跃，换手率分别为2033.57%、487.23%、199.08%，振幅较大的相关个股有Chimerix, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 、Jupiter Neurosciences, Inc.，振幅分别为154.91%、131.78%、121.49%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241211045253984b1dd1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241211045253984b1dd1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","PRQR"],"gpt_icon":0},{"id":"2489450677","title":"Proqr Therapeutics N.V.盘中异动 早盘股价大涨5.19%报3.65美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2489450677","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489450677?lang=zh_cn&edition=full","pubTime":"2024-12-05 22:39","pubTimestamp":1733409592,"startTime":"0","endTime":"0","summary":"北京时间2024年12月05日22时39分，Proqr Therapeutics N.V.股票出现异动，股价快速上涨5.19%。截至发稿，该股报3.65美元/股，成交量5.1228万股，换手率0.05%，振幅4.73%。Proqr Therapeutics N.V.股票所在的生物技术行业中，整体跌幅为0.06%。其相关个股中，Protara Therapeutics, Inc.、Nls Pharmaceutics Ltd C/Wts 02/02/2026、Conduit Pharmaceuticals Inc C/Wts 22/09/2028涨幅较大，Psyence Biomedical Ltd.、Protara Therapeutics, Inc.、Silexion Therapeutics Corp较为活跃，换手率分别为1945.79%、272.62%、208.08%，振幅较大的相关个股有Protara Therapeutics, Inc.、Psyence Biomedical Ltd.、Lipella Pharmaceuticals Inc.，振幅分别为38.70%、29.76%、16.61%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024120522395698e59e7a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024120522395698e59e7a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","PRQR","BK4139"],"gpt_icon":0},{"id":"2488519060","title":"Proqr Therapeutics N.V.盘中异动 早盘股价大跌5.18%报3.48美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2488519060","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488519060?lang=zh_cn&edition=full","pubTime":"2024-12-04 22:58","pubTimestamp":1733324311,"startTime":"0","endTime":"0","summary":"北京时间2024年12月04日22时58分，Proqr Therapeutics N.V.股票出现波动，股价急速下跌5.18%。截至发稿，该股报3.48美元/股，成交量6.1868万股，换手率0.06%，振幅3.81%。Proqr Therapeutics N.V.股票所在的生物技术行业中，整体涨幅为0.01%。其相关个股中，Cyclerion Therapeutics, Inc.、Exicure, Inc.、Heron Therapeutics, Inc.涨幅较大，Cyclerion Therapeutics, Inc.、Can Fite Biopharma Ltd、Windtree Therapeutics, Inc.较为活跃，换手率分别为2239.25%、215.35%、119.94%，振幅较大的相关个股有Cyclerion Therapeutics, Inc.、Eterna Therapeutics Inc.、Heron Therapeutics, Inc.，振幅分别为237.89%、48.53%、34.75%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024120422583198e55e41&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024120422583198e55e41&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","PRQR"],"gpt_icon":0},{"id":"2488466099","title":"Proqr Therapeutics N.V.盘中异动 股价大跌5.63%","url":"https://stock-news.laohu8.com/highlight/detail?id=2488466099","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488466099?lang=zh_cn&edition=full","pubTime":"2024-12-03 22:31","pubTimestamp":1733236267,"startTime":"0","endTime":"0","summary":"北京时间2024年12月03日22时31分，Proqr Therapeutics N.V.股票出现异动，股价快速跳水5.63%。Proqr Therapeutics N.V.股票所在的生物技术行业中，整体跌幅为0.25%。Proqr Therapeutics N.V.公司简介：ProQR Therapeutics NV is a biopharmaceutical company, which engages in the discovery and development of Ribonucleic Acid RNA based therapeutics for the treatment of genetic disorders. Its initial focus is on the development of a disease-modifying therapy for the treatment of cystic fibrosis. The company was founded by Daniel de Boer, Gerard Platenburg, Henri Termeer and Dinko Valerio on February 21, 2012 and is headquartered in Leiden, the Netherlands.（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241203223107a26994bf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241203223107a26994bf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","PRQR"],"gpt_icon":0},{"id":"2486033798","title":"Proqr Therapeutics N.V.盘中异动 下午盘股价大涨5.52%报3.63美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2486033798","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486033798?lang=zh_cn&edition=full","pubTime":"2024-11-28 02:26","pubTimestamp":1732731979,"startTime":"0","endTime":"0","summary":"北京时间2024年11月28日02时26分，Proqr Therapeutics N.V.股票出现异动，股价快速拉升5.52%。截至发稿，该股报3.63美元/股，成交量11.7255万股，换手率0.11%，振幅5.52%。Proqr Therapeutics N.V.股票所在的生物技术行业中，整体涨幅为0.55%。其相关个股中，Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Protagenic Therapeutics Inc C/Wts 29/04/2026 、Rocket Pharmaceuticals Inc C/Wts 02/09/2026 涨幅较大，Cyclerion Therapeutics, Inc.、Outlook Therapeutics, Inc.、Tc Biopharm  Plc较为活跃，换手率分别为996.12%、242.90%、54.32%，振幅较大的相关个股有Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Silexion Therapeutics Corp C/Wts Exp 15/08/2029 、Protagenic Therapeutics Inc C/Wts 29/04/2026 ，振幅分别为86.60%、79.26%、78.75%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112802261998e44fe1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112802261998e44fe1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PRQR","LENZ"],"gpt_icon":0},{"id":"2484676787","title":"Proqr Therapeutics N.V.盘中异动 快速下挫5.75%","url":"https://stock-news.laohu8.com/highlight/detail?id=2484676787","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484676787?lang=zh_cn&edition=full","pubTime":"2024-11-18 22:47","pubTimestamp":1731941243,"startTime":"0","endTime":"0","summary":"北京时间2024年11月18日22时47分，Proqr Therapeutics N.V.股票出现波动，股价快速下挫5.75%。Proqr Therapeutics N.V.股票所在的生物技术行业中，整体跌幅为0.24%。其相关个股中，Hcw Biologics Inc.、冠科美博、Fate Therapeutics, Inc.涨幅较大，Tharimmune, Inc.、Hcw Biologics Inc.、冠科美博较为活跃，换手率分别为545.86%、368.45%、277.15%，振幅较大的相关个股有Hcw Biologics Inc.、Fate Therapeutics, Inc.、冠科美博，振幅分别为118.81%、62.38%、54.54%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241118224723a2433349&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241118224723a2433349&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PRQR","BK4139","LENZ"],"gpt_icon":0},{"id":"2483085804","title":"Proqr Therapeutics N.V.盘中异动 股价大涨5.01%报4.18美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483085804","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483085804?lang=zh_cn&edition=full","pubTime":"2024-11-14 02:22","pubTimestamp":1731522131,"startTime":"0","endTime":"0","summary":"北京时间2024年11月14日02时22分，Proqr Therapeutics N.V.股票出现异动，股价大幅拉升5.01%。截至发稿，该股报4.18美元/股，成交量98.6188万股，换手率0.96%，振幅5.95%。Proqr Therapeutics N.V.股票所在的生物技术行业中，整体跌幅为0.31%。其相关个股中，Nkgen Biotech Inc C/Wts 31/05/2028、Pulmatrix, Inc.、Calidi Biotherapeutics, Inc.涨幅较大，Cyclacel Pharmaceuticals, Inc.、Elevai Labs, Inc.、Calidi Biotherapeutics, Inc.较为活跃，换手率分别为536.10%、395.72%、143.28%，振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Celularity Inc C/Wts 16/07/2026 、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 ，振幅分别为128.00%、73.71%、71.97%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114022211abbe539c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114022211abbe539c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","PRQR","BK4139"],"gpt_icon":0},{"id":"2482734549","title":"Proqr Therapeutics N.V.2024财年第三财季实现净利润-8.91百万美元，同比减少43.48%","url":"https://stock-news.laohu8.com/highlight/detail?id=2482734549","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482734549?lang=zh_cn&edition=full","pubTime":"2024-11-12 00:00","pubTimestamp":1731340831,"startTime":"0","endTime":"0","summary":"11月12日，Proqr Therapeutics N.V.公布财报，公告显示公司2024财年第三财季净利润为-8.91百万美元，同比减少43.48%；其中营业收入为4.22百万美元，同比增加183.22%，每股基本收益为-0.11美元。从资产负债表来看，Proqr Therapeutics N.V.总负债91.37百万美元，其中短期债务4.78百万美元，资产负债比为0.02，流动比率为0.03。机构评级：截至2024年11月12日，当前有6家机构对Proqr Therapeutics N.V.目标价做出预测，其中目标均价为6.63美元，其中最低目标价为2.07美元，最高目标价为13.95美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241112000040a22d0d7c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241112000040a22d0d7c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","PRQR"],"gpt_icon":0},{"id":"2482246738","title":"Proqr Therapeutics N.V.盘中异动 快速上涨7.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2482246738","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482246738?lang=zh_cn&edition=full","pubTime":"2024-11-11 22:38","pubTimestamp":1731335922,"startTime":"0","endTime":"0","summary":"北京时间2024年11月11日22时38分，Proqr Therapeutics N.V.股票出现波动，股价急速拉升7.16%。截至发稿，该股报4.04美元/股，成交量4.6886万股，换手率0.05%，振幅107.16%。Proqr Therapeutics N.V.股票所在的生物技术行业中，整体跌幅为0.26%。其相关个股中，Cero Therapeutics Holdings, Inc.、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Revelation Biosciences, Inc.涨幅较大，Revelation Biosciences, Inc.、Cero Therapeutics Holdings, Inc.、Elevai Labs, Inc.较为活跃，换手率分别为420.10%、157.16%、81.94%，振幅较大的相关个股有Proqr Therapeutics N.V.、Praxis Precision Medicines, Inc.、Cero Therapeutics Holdings, Inc.，振幅分别为107.16%、104.19%、59.00%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111122384398e41ca4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111122384398e41ca4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","PRQR"],"gpt_icon":0},{"id":"2481610102","title":"Proqr Therapeutics N.V.盘中异动 股价大涨5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481610102","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481610102?lang=zh_cn&edition=full","pubTime":"2024-11-08 22:34","pubTimestamp":1731076446,"startTime":"0","endTime":"0","summary":"北京时间2024年11月08日22时34分，Proqr Therapeutics N.V.股票出现波动，股价急速上涨5.00%。截至发稿，该股报3.75美元/股，成交量2.1394万股，换手率0.02%，振幅1.90%。Proqr Therapeutics N.V.股票所在的生物技术行业中，整体涨幅为0.31%。其相关个股中，Psyence Biomedical Ltd C/Wts 25/01/2029、Fortrea Holdings Inc.、Poseida Therapeutics, Inc.涨幅较大，Elevai Labs, Inc.、Matinas Biopharma Holdings, Inc.、Lipella Pharmaceuticals Inc.较为活跃，换手率分别为395.92%、16.85%、14.88%，振幅较大的相关个股有Cardiff Oncology, Inc.、Rigel Pharmaceuticals, Inc.、Anebulo Pharmaceuticals, Inc.，振幅分别为18.09%、16.52%、14.96%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241108223407971a55dd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241108223407971a55dd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","PRQR","BK4139"],"gpt_icon":0},{"id":"2481153143","title":"Proqr Therapeutics N.V.盘中异动 股价大跌5.09%报3.54美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2481153143","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481153143?lang=zh_cn&edition=full","pubTime":"2024-11-05 01:24","pubTimestamp":1730741062,"startTime":"0","endTime":"0","summary":"北京时间2024年11月05日01时24分，Proqr Therapeutics N.V.股票出现波动，股价大幅下挫5.09%。截至发稿，该股报3.54美元/股，成交量18.6108万股，换手率0.18%，振幅6.97%。Proqr Therapeutics N.V.股票所在的生物技术行业中，整体跌幅为0.07%。其相关个股中，Neurogene Inc.、Tenaya Therapeutics, Inc.、Disc Medicine, Inc.涨幅较大，Elevai Labs, Inc.、Nls Pharmaceutics Ltd.、Gri Bio, Inc.较为活跃，换手率分别为352.20%、274.99%、79.03%，振幅较大的相关个股有Sab Biotherapeutics Inc C/Wts 22/10/2026 、In8Bio, Inc.、Kazia Therapeutics Limited，振幅分别为52.25%、45.39%、39.13%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241105012422a21595cf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241105012422a21595cf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","PRQR"],"gpt_icon":0},{"id":"2480057977","title":"Proqr Therapeutics N.V.盘中异动 下午盘急速下挫5.19%报3.47美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2480057977","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480057977?lang=zh_cn&edition=full","pubTime":"2024-11-01 02:23","pubTimestamp":1730399002,"startTime":"0","endTime":"0","summary":"北京时间2024年11月01日02时23分，Proqr Therapeutics N.V.股票出现波动，股价大幅下挫5.19%。截至发稿，该股报3.47美元/股，成交量27.5494万股，换手率0.27%，振幅4.64%。Proqr Therapeutics N.V.股票所在的生物技术行业中，整体跌幅为3.50%。其相关个股中，Revolution Medicines Inc C/Wts 17/12/2026 、Ocean Biomedical Inc C/Wts 14/02/2028 、Karyopharm Therapeutics Inc.涨幅较大，Aditxt, Inc.、Evogene Ltd.、Gri Bio, Inc.较为活跃，换手率分别为272.26%、241.78%、196.37%，振幅较大的相关个股有Revolution Medicines Inc C/Wts 17/12/2026 、Vaccinex, Inc.、180 Life Sciences Corp C/Wts 07/11/2025，振幅分别为80.77%、47.15%、46.15%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110102232298e3fc80&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110102232298e3fc80&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","PRQR"],"gpt_icon":0},{"id":"2479283593","title":"Proqr Therapeutics N.V.盘中异动 早盘急速上涨15.86%","url":"https://stock-news.laohu8.com/highlight/detail?id=2479283593","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479283593?lang=zh_cn&edition=full","pubTime":"2024-10-29 21:32","pubTimestamp":1730208731,"startTime":"0","endTime":"0","summary":"北京时间2024年10月29日21时32分，Proqr Therapeutics N.V.股票出现异动，股价急速拉升15.86%。截至发稿，该股报3.84美元/股，成交量21.5493万股，换手率0.22%，振幅6.34%。Proqr Therapeutics N.V.股票所在的生物技术行业中，整体跌幅为0.20%。其相关个股中，Glycomimetics, Inc.、Cardio Diagnostics Holdings Inc C/Wts  To Pur Com、Lixte Biotechnology Holdings, Inc.涨幅较大，Lixte Biotechnology Holdings, Inc.、Novabay Pharmaceuticals, Inc.、Glycomimetics, Inc.较为活跃，换手率分别为519.07%、248.80%、128.71%，振幅较大的相关个股有Glycomimetics, Inc.、Entero Therapeutics Inc.、Sangamo Therapeutics, Inc.，振幅分别为22.06%、11.54%、10.29%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102921321195bd81f9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102921321195bd81f9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PRQR","LENZ","BK4139"],"gpt_icon":0},{"id":"2477853389","title":"Proqr Therapeutics N.V.盘中异动 早盘大幅下挫5.29%报3.58美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2477853389","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477853389?lang=zh_cn&edition=full","pubTime":"2024-10-23 21:34","pubTimestamp":1729690494,"startTime":"0","endTime":"0","summary":"北京时间2024年10月23日21时34分，Proqr Therapeutics N.V.股票出现波动，股价大幅下挫5.29%。截至发稿，该股报3.58美元/股，成交量51.6813万股，换手率0.63%，振幅5.29%。Proqr Therapeutics N.V.股票所在的生物技术行业中，整体跌幅为0.33%。其相关个股中，Cns Pharmaceuticals, Inc.、Virax Biolabs Group Limited、Dbv Technologies涨幅较大，Virax Biolabs Group Limited、Cns Pharmaceuticals, Inc.、Cyclacel Pharmaceuticals, Inc.较为活跃，换手率分别为1002.98%、537.54%、280.48%，振幅较大的相关个股有Cns Pharmaceuticals, Inc.、Virax Biolabs Group Limited、Tevogen Bio Holdings Inc.，振幅分别为42.95%、28.57%、23.60%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241023213454ab6d703c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241023213454ab6d703c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PRQR","LENZ","BK4139"],"gpt_icon":0},{"id":"2477587474","title":"BUZZ--美国股票走势-可口可乐公司、精神航空公司、波音公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2477587474","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477587474?lang=zh_cn&edition=full","pubTime":"2024-10-23 21:14","pubTimestamp":1729689272,"startTime":"0","endTime":"0","summary":"        *      Eikon 个股走势搜索字符串：[STXBZ］        *      The Day Ahead 新闻通讯：          *      The Morning News Call时事通讯：      10月23日 - 美国股指期货周三再次出现低开的迹象，原因是国债收益率受央行可能收敛的担忧影响而上扬，同时投资者关注可口可乐和星巴克等公司的财报。美东时间9:01，道指电子盘  下跌 0.56%，报 42,927 点。标普500指数小型股  下跌0.36%，报5871.25点；纳斯达克100指数小型股  下跌0.46%，报20448.25点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BSX","LU2048586759.USD","LU1069344957.HKD","LU2087625088.SGD","LU0528227936.USD","HLT","LU1543694498.USD","QCOM","T","IE00B4R5TH58.HKD","LU0267386448.USD","LU0175139822.USD","SBUX","BK4515","SAVE","LU1917777945.USD","AOS","NEE","PRQR","TMO","IE00BMQBXF63.USD","LU0957791311.USD","APH","LU0795875086.SGD","BK4585","LU2106854487.HKD","LU0320765646.SGD","NEP","LU0314104364.USD","LU2491050071.SGD","IE0009355771.USD","GEV","LU1923622614.USD","LU0154245673.USD","LU0345774631.USD","TXN","LU0096362180.USD","LRN","BA","KO","LU1221951046.USD","LU1868837300.USD","BK4082","LU0545039389.USD"],"gpt_icon":1},{"id":"2477581531","title":"BUZZ-ProQR Therapeutics 募集 7,500 万美元股本后股价下跌，礼来公司参与投资","url":"https://stock-news.laohu8.com/highlight/detail?id=2477581531","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477581531?lang=zh_cn&edition=full","pubTime":"2024-10-23 20:25","pubTimestamp":1729686305,"startTime":"0","endTime":"0","summary":"    10月23日 - ** ProQR Therapeutics N.V.  股价盘前下跌 4%，至 3.63 美元。** 总部位于荷兰的 RNA 编辑公司周二晚些时候宣布，  1800 万股，发行价为 3.50 美元，募集资金总额为 630 万美元。** 公司计划将这两项交易的净收益用于研发、临床开发/推进未来候选产品以及其他用途** PRQR 拥有约 8168 万股流通股，市值约 3.09 亿美元** 截至本周二，该公司股价在过去一周内上涨了一倍多，其中 10 月 16 日大涨 122%。** Evercore、Cantor、Raymond James 和 Oppenheimer 是此次股票发行的主要账簿管理人。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","IE00BJLML261.HKD","IE00BK4W5M84.HKD","LU0320765059.SGD","LU0882574055.USD","LU1069344957.HKD","LU1023059063.AUD","LU0471298777.SGD","BK4007","LU0058720904.USD","IE0004445239.USD","LU0097036916.USD","LENZ","LU0096364046.USD","LU0385154629.USD","LU0456855351.SGD","LU0289739699.SGD","IE0009355771.USD","LU0689472784.USD","IE0002141913.USD","LU0238689110.USD","LU0122379950.USD","IE00B4R5TH58.HKD","LU0417517546.SGD","LU0471298694.HKD","BK4588","LU0094547139.USD","LU0640476718.USD","PRQR","IE00BJT1NW94.SGD","LU0256863902.USD","LU0823416689.USD","IE00B1BXHZ80.USD","BK4585","BK4533","LU0672654240.SGD","LU0882574139.USD","LU0198837287.USD","LLY","LU1035775433.USD","LU0106261372.USD","IE00BJJMRZ35.SGD","LU0466842654.USD","LU0943347566.SGD","IE00B2B36J28.USD","LU0114720955.EUR","IE00BK4W5L77.USD","LU0203202063.USD","LU1093756168.USD","LU0006306889.USD"],"gpt_icon":0},{"id":"2477375673","title":"Proqr Therapeutics N.V.盘中异动 早盘快速下挫5.92%","url":"https://stock-news.laohu8.com/highlight/detail?id=2477375673","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477375673?lang=zh_cn&edition=full","pubTime":"2024-10-22 21:33","pubTimestamp":1729604017,"startTime":"0","endTime":"0","summary":"北京时间2024年10月22日21时33分，Proqr Therapeutics N.V.股票出现异动，股价大幅下挫5.92%。Proqr Therapeutics N.V.股票所在的生物技术行业中，整体跌幅为0.46%。Proqr Therapeutics N.V.公司简介：ProQR Therapeutics NV is a biopharmaceutical company, which engages in the discovery and development of Ribonucleic Acid RNA based therapeutics for the treatment of genetic disorders. Its initial focus is on the development of a disease-modifying therapy for the treatment of cystic fibrosis. The company was founded by Daniel de Boer, Gerard Platenburg, Henri Termeer and Dinko Valerio on February 21, 2012 and is headquartered in Leiden, the Netherlands.（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241022213337ab6c3dde&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241022213337ab6c3dde&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PRQR","BK4139","LENZ"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.proqr.com","stockEarnings":[{"period":"1week","weight":-0.0707},{"period":"1month","weight":-0.2834},{"period":"3month","weight":0.5202},{"period":"6month","weight":0.538},{"period":"1year","weight":0.3085},{"period":"ytd","weight":0.3283}],"compareEarnings":[{"period":"1week","weight":-0.0221},{"period":"1month","weight":0.0006},{"period":"3month","weight":0.0397},{"period":"6month","weight":0.0851},{"period":"1year","weight":0.2499},{"period":"ytd","weight":0.243}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"ProQR Therapeutics N.V.是一家于2012年2月21日在荷兰成立的有限责任公司。该公司是一家生物技术公司，致力于创造变革性的RNA疗法，以改善受严重未满足医疗需求的疾病影响的患者和家庭的生活。为了实现这一目标，该公司正在推进专有的Axiomer RNA编辑平台技术。该公司相信，通过这种RNA编辑机制发挥作用的药物有潜力成为一类新的创新药物，适用于广泛的治疗领域。","yearOnYearQuotes":[{"month":1,"riseRate":0.2,"avgChangeRate":-0.134798},{"month":2,"riseRate":0.4,"avgChangeRate":-0.111432},{"month":3,"riseRate":0.6,"avgChangeRate":0.040533},{"month":4,"riseRate":0.3,"avgChangeRate":-0.046548},{"month":5,"riseRate":0.5,"avgChangeRate":0.027083},{"month":6,"riseRate":0.5,"avgChangeRate":0.013624},{"month":7,"riseRate":0.4,"avgChangeRate":-0.034331},{"month":8,"riseRate":0.8,"avgChangeRate":0.085978},{"month":9,"riseRate":0.3,"avgChangeRate":0.084324},{"month":10,"riseRate":0.272727,"avgChangeRate":0.015855},{"month":11,"riseRate":0.636364,"avgChangeRate":0.058476},{"month":12,"riseRate":0.636364,"avgChangeRate":0.231912}],"exchange":"NASDAQ","name":"ProQR Therapeutics N.V.","nameEN":"ProQR Therapeutics NV"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"ProQR Therapeutics N.V.(PRQR)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供ProQR Therapeutics N.V.(PRQR)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"ProQR Therapeutics N.V.,PRQR,ProQR Therapeutics N.V.股票,ProQR Therapeutics N.V.股票老虎,ProQR Therapeutics N.V.股票老虎国际,ProQR Therapeutics N.V.行情,ProQR Therapeutics N.V.股票行情,ProQR Therapeutics N.V.股价,ProQR Therapeutics N.V.股市,ProQR Therapeutics N.V.股票价格,ProQR Therapeutics N.V.股票交易,ProQR Therapeutics N.V.股票购买,ProQR Therapeutics N.V.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"ProQR Therapeutics N.V.(PRQR)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供ProQR Therapeutics N.V.(PRQR)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}